Neurocrine Partners With Takeda to Address Psychiatric Disorders

San Diego – June 29, 2020 – Cooley advised Neurocrine Biosciences on its strategic partnership agreement with Takeda to develop and commercialize potential therapies in Takeda’s early- to mid-stage pipeline for psychiatric disorders. The partnership will enhance Neurocrine’s growing pipeline of treatments and strengthen the company’s position as a leading neuroscience-focused biopharmaceutical company. Cooley lawyers Kay Chandler and Rena Kaminsky led the team advising Neurocrine.

“We are excited to collaborate with Takeda to bring life-changing therapies to people living with serious, challenging and under-addressed psychiatric disorders who are in need of better treatment options,” Neurocrine CEO Kevin Gorman said in a statement. “With our deep understanding in the fields of psychiatry and neurology, we look forward to developing new treatments for schizophrenia, treatment-resistant depression and anhedonia as part of our diverse clinical development pipeline.”

Neurocrine will develop and commercialize all pipeline compounds included in the collaboration. Under the terms of the agreement, Neurocrine will pay Takeda $120 million in upfront cash and up to $495 million in development milestones, $1.4 billion in commercial milestones and double-digit royalties on net sales.

Headquartered in San Diego, Neurocrine specializes in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson’s disease, endometriosis and uterine fibroids and clinical development programs in multiple therapeutic areas. 

Last year, Cooley advised Neurocrine on a collaboration agreement with Xenon and with Voyager.  

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. 

Cooley has 1,100+ lawyers across 16 offices in the United States, Asia and Europe.

Related Contacts
Kay Chandler Partner, San Diego
Rena Kaminsky Special Counsel, Palo Alto
Jacqueline Grise Partner, Washington, DC
Megan Browdie Partner, Washington, DC
Jason Kent Partner, San Diego
Carlos Ramirez Associate, San Diego
Mika Reiner Mayer Partner, Palo Alto
Kimberly Bolin Patent Agent, Palo Alto
Catherine O. Liang Associate, Palo Alto
Matthew C. Stevens Patent Agent, Palo Alto
Connie Tong Patent Agent, Palo Alto
Natasha Leskovsek Of Counsel, Washington, DC
Stephanie Gentile Partner, New York
Amanda Pacheco Associate, Palo Alto